CN Stock MarketDetailed Quotes

600518 Kangmei Pharmaceutical

Watchlist
  • 2.36
  • -0.12-4.84%
Market Closed Nov 15 15:00 CST
32.72BMarket Cap131.11P/E (TTM)

Kangmei Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
9.60%3.87B
4.09%2.47B
5.01%1.2B
16.60%4.87B
29.84%3.53B
33.62%2.38B
22.50%1.14B
0.67%4.18B
-11.80%2.72B
-14.04%1.78B
Operating revenue
9.60%3.87B
4.09%2.47B
5.01%1.2B
16.60%4.87B
29.84%3.53B
33.62%2.38B
22.50%1.14B
0.67%4.18B
-11.80%2.72B
-14.04%1.78B
Other operating revenue
----
-32.01%16.7M
----
149.66%47.3M
----
110.39%24.56M
----
-80.82%18.95M
----
-81.54%11.67M
Total operating cost
6.31%4.08B
0.52%2.59B
3.28%1.27B
0.10%4.89B
26.48%3.84B
30.25%2.58B
17.79%1.23B
-25.00%4.89B
-30.20%3.03B
-38.44%1.98B
Operating cost
13.27%3.33B
7.79%2.11B
4.58%1.03B
13.96%4.04B
29.95%2.94B
32.15%1.96B
23.59%982.88M
1.75%3.55B
-10.13%2.26B
-11.85%1.48B
Operating tax surcharges
-36.33%34.37M
-46.55%22.26M
-12.96%11.19M
-240.45%-274.18M
309.03%53.98M
56.77%41.64M
-1.91%12.85M
-70.13%195.22M
-72.57%13.2M
-16.95%26.56M
Operating expense
-28.44%312.99M
-37.96%191.81M
-7.72%95.76M
18.24%551.78M
47.21%437.36M
66.86%309.16M
18.46%103.77M
3.74%466.64M
-13.11%297.11M
-25.56%185.28M
Administration expense
-2.27%376M
-3.78%244.84M
0.38%126.37M
-18.29%502.12M
-17.11%384.72M
-11.35%254.45M
-17.03%125.9M
-28.24%614.49M
-15.40%464.16M
-21.68%287.04M
Financial expense
79.00%-2.87M
85.71%-1.27M
81.87%-821.58K
-33.59%27.12M
32.18%-13.68M
34.80%-8.92M
36.08%-4.53M
-96.16%40.84M
-102.29%-20.18M
-101.56%-13.69M
-Interest expense (Financial expense)
-8.78%8.55M
-2.67%6.09M
-0.54%2.99M
-28.83%56.15M
18.79%9.37M
22.13%6.26M
17.73%3M
-92.28%78.9M
-99.06%7.89M
-99.39%5.12M
-Interest Income (Financial expense)
50.49%-12.15M
51.96%-7.84M
48.69%-4.03M
23.19%-30.74M
17.43%-24.54M
18.62%-16.33M
20.79%-7.86M
-659.36%-40.03M
-1,301.73%-29.73M
-1,503.53%-20.06M
Research and development
-15.00%32.16M
-3.36%22.79M
9.23%10.36M
79.27%45.62M
95.81%37.84M
91.72%23.58M
141.65%9.49M
174.41%25.45M
70.48%19.33M
44.01%12.3M
Credit Impairment Loss
-16.08%55.99M
560.66%48.91M
46,711.60%13.58M
188.87%202.17M
1,731.73%66.71M
124.81%7.4M
99.78%-29.13K
89.59%-227.48M
85.40%-4.09M
-0.40%-29.83M
Asset Impairment Loss
-159.52%-465.84K
-163.50%-467.4K
-99.54%1.59K
60.26%-197.55M
482.85%782.69K
225.72%736.11K
91.34%348.36K
84.43%-497.16M
-117.67%-204.44K
25.39%-585.5K
Other net revenue
0.46%163.38M
59.33%138.37M
121.35%79.11M
110.04%107.27M
1,060.31%162.63M
901.60%86.85M
1,071.37%35.74M
-108.56%-1.07B
-94.51%14.02M
-104.46%-10.83M
Fair value change income
98.47%-395.39
42.44%-10.04K
---5.26K
---34.51K
---25.85K
---17.45K
----
----
----
----
Invest income
91.09%63.65M
91.10%41.8M
412.09%29.53M
5,849.29%44.43M
24,761.53%33.31M
285,176.16%21.87M
95,704.45%5.77M
-99.60%746.87K
-99.92%133.97K
-100.00%7.67K
Asset deal income
37.87%28.21M
39.23%28.36M
29.59%26.13M
1,902.41%19.61M
3,026.64%20.46M
3,694.12%20.37M
6,459.68%20.16M
-98.47%979.19K
-98.59%654.34K
-98.85%536.9K
Other revenue
-61.33%16.01M
-45.78%19.78M
4.10%9.88M
111.20%38.65M
136.28%41.4M
91.62%36.48M
4.15%9.49M
-101.96%-344.99M
-69.73%17.52M
-60.87%19.04M
Operating profit
70.68%-40.79M
115.47%18.16M
118.92%9.59M
104.88%86.67M
53.14%-139.12M
45.07%-117.36M
55.70%-50.67M
-117.58%-1.78B
70.42%-296.89M
76.45%-213.67M
Add:Non operating Income
194.38%66.41M
-47.88%9.1M
-92.15%583.5K
81.67%57.88M
-21.95%22.56M
-34.56%17.45M
288.51%7.43M
30.42%31.86M
307.34%28.9M
748.22%26.67M
Less:Non operating expense
-59.20%6.52M
-84.35%2.43M
-52.19%508.1K
-96.28%34.18M
-97.37%15.99M
161.22%15.56M
65.97%1.06M
-53.62%918.37M
32,945.70%608.74M
411.66%5.96M
Total profit
114.41%19.1M
121.49%24.82M
121.82%9.66M
104.14%110.37M
84.88%-132.55M
40.16%-115.47M
60.83%-44.3M
-132.67%-2.66B
12.19%-876.73M
78.68%-192.96M
Less:Income tax cost
-21.49%10.98M
-30.20%6.7M
-80.75%1.05M
-77.14%6.8M
68.18%13.99M
275.97%9.59M
451.13%5.46M
-87.36%29.75M
-70.88%8.32M
-90.70%2.55M
Net profit
FLtoP8.11M
FLtoP18.12M
FLtoP8.61M
FLtoP103.57M
FPtoL-146.54M
FPtoL-125.06M
FPtoL-49.77M
SL-2.69B
FPtoL-885.05M
FPtoL-195.51M
Net profit from continuing operation
105.53%8.11M
114.49%18.12M
117.31%8.61M
103.84%103.57M
83.44%-146.54M
36.03%-125.06M
55.39%-49.77M
-134.01%-2.69B
13.83%-885.05M
79.04%-195.51M
Less:Minority Profit
110.52%3.1M
197.51%2.36M
77.48%1.14M
118.54%1.05M
103.32%1.47M
488.60%793.21K
575.89%643.19K
-381.56%-5.64M
129.44%723.15K
104.29%134.76K
Net profit of parent company owners
103.39%5.02M
112.52%15.76M
114.82%7.47M
103.81%102.52M
83.29%-148.01M
35.67%-125.86M
54.76%-50.41M
-133.95%-2.69B
13.55%-885.77M
78.95%-195.65M
Earning per share
Basic earning per share
--0
111.11%0.001
125.00%0.001
105.26%0.01
82.81%-0.011
35.71%-0.009
50.00%-0.004
-133.33%-0.19
13.51%-0.064
79.10%-0.014
Diluted earning per share
--0
111.11%0.001
125.00%0.001
105.26%0.01
82.81%-0.011
35.71%-0.009
50.00%-0.004
-133.33%-0.19
13.51%-0.064
79.10%-0.014
Other composite income
-781.50%-118.14K
-1,878.74%-151.92K
-3,977.41%-21.77K
-158.78%-235.82K
-556.27%-13.4K
238.16%8.54K
-533.98
-88.44%401.22K
-98.10%2.94K
-98.41%2.53K
Other composite income of parent company owners
-781.50%-118.14K
-1,878.74%-151.92K
-3,977.41%-21.77K
-158.78%-235.82K
-556.27%-13.4K
238.16%8.54K
---533.98
-88.44%401.22K
-98.10%2.94K
-98.41%2.53K
Total composite income
105.45%7.99M
114.37%17.97M
117.26%8.59M
103.84%103.33M
83.44%-146.55M
36.04%-125.06M
55.39%-49.77M
-133.99%-2.69B
13.81%-885.04M
79.03%-195.51M
Total composite income of parent company owners
103.31%4.9M
112.40%15.61M
114.78%7.45M
103.81%102.29M
83.29%-148.02M
35.67%-125.85M
54.76%-50.41M
-133.93%-2.69B
13.54%-885.77M
78.95%-195.64M
Total composite income of minority owners
110.52%3.1M
197.51%2.36M
77.48%1.14M
118.54%1.05M
103.32%1.47M
488.60%793.21K
575.89%643.19K
-381.56%-5.64M
129.44%723.15K
104.29%134.76K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianji International Accounting Firm (Special General Partnership)
--
--
--
Tianji International Accounting Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 9.60%3.87B4.09%2.47B5.01%1.2B16.60%4.87B29.84%3.53B33.62%2.38B22.50%1.14B0.67%4.18B-11.80%2.72B-14.04%1.78B
Operating revenue 9.60%3.87B4.09%2.47B5.01%1.2B16.60%4.87B29.84%3.53B33.62%2.38B22.50%1.14B0.67%4.18B-11.80%2.72B-14.04%1.78B
Other operating revenue -----32.01%16.7M----149.66%47.3M----110.39%24.56M-----80.82%18.95M-----81.54%11.67M
Total operating cost 6.31%4.08B0.52%2.59B3.28%1.27B0.10%4.89B26.48%3.84B30.25%2.58B17.79%1.23B-25.00%4.89B-30.20%3.03B-38.44%1.98B
Operating cost 13.27%3.33B7.79%2.11B4.58%1.03B13.96%4.04B29.95%2.94B32.15%1.96B23.59%982.88M1.75%3.55B-10.13%2.26B-11.85%1.48B
Operating tax surcharges -36.33%34.37M-46.55%22.26M-12.96%11.19M-240.45%-274.18M309.03%53.98M56.77%41.64M-1.91%12.85M-70.13%195.22M-72.57%13.2M-16.95%26.56M
Operating expense -28.44%312.99M-37.96%191.81M-7.72%95.76M18.24%551.78M47.21%437.36M66.86%309.16M18.46%103.77M3.74%466.64M-13.11%297.11M-25.56%185.28M
Administration expense -2.27%376M-3.78%244.84M0.38%126.37M-18.29%502.12M-17.11%384.72M-11.35%254.45M-17.03%125.9M-28.24%614.49M-15.40%464.16M-21.68%287.04M
Financial expense 79.00%-2.87M85.71%-1.27M81.87%-821.58K-33.59%27.12M32.18%-13.68M34.80%-8.92M36.08%-4.53M-96.16%40.84M-102.29%-20.18M-101.56%-13.69M
-Interest expense (Financial expense) -8.78%8.55M-2.67%6.09M-0.54%2.99M-28.83%56.15M18.79%9.37M22.13%6.26M17.73%3M-92.28%78.9M-99.06%7.89M-99.39%5.12M
-Interest Income (Financial expense) 50.49%-12.15M51.96%-7.84M48.69%-4.03M23.19%-30.74M17.43%-24.54M18.62%-16.33M20.79%-7.86M-659.36%-40.03M-1,301.73%-29.73M-1,503.53%-20.06M
Research and development -15.00%32.16M-3.36%22.79M9.23%10.36M79.27%45.62M95.81%37.84M91.72%23.58M141.65%9.49M174.41%25.45M70.48%19.33M44.01%12.3M
Credit Impairment Loss -16.08%55.99M560.66%48.91M46,711.60%13.58M188.87%202.17M1,731.73%66.71M124.81%7.4M99.78%-29.13K89.59%-227.48M85.40%-4.09M-0.40%-29.83M
Asset Impairment Loss -159.52%-465.84K-163.50%-467.4K-99.54%1.59K60.26%-197.55M482.85%782.69K225.72%736.11K91.34%348.36K84.43%-497.16M-117.67%-204.44K25.39%-585.5K
Other net revenue 0.46%163.38M59.33%138.37M121.35%79.11M110.04%107.27M1,060.31%162.63M901.60%86.85M1,071.37%35.74M-108.56%-1.07B-94.51%14.02M-104.46%-10.83M
Fair value change income 98.47%-395.3942.44%-10.04K---5.26K---34.51K---25.85K---17.45K----------------
Invest income 91.09%63.65M91.10%41.8M412.09%29.53M5,849.29%44.43M24,761.53%33.31M285,176.16%21.87M95,704.45%5.77M-99.60%746.87K-99.92%133.97K-100.00%7.67K
Asset deal income 37.87%28.21M39.23%28.36M29.59%26.13M1,902.41%19.61M3,026.64%20.46M3,694.12%20.37M6,459.68%20.16M-98.47%979.19K-98.59%654.34K-98.85%536.9K
Other revenue -61.33%16.01M-45.78%19.78M4.10%9.88M111.20%38.65M136.28%41.4M91.62%36.48M4.15%9.49M-101.96%-344.99M-69.73%17.52M-60.87%19.04M
Operating profit 70.68%-40.79M115.47%18.16M118.92%9.59M104.88%86.67M53.14%-139.12M45.07%-117.36M55.70%-50.67M-117.58%-1.78B70.42%-296.89M76.45%-213.67M
Add:Non operating Income 194.38%66.41M-47.88%9.1M-92.15%583.5K81.67%57.88M-21.95%22.56M-34.56%17.45M288.51%7.43M30.42%31.86M307.34%28.9M748.22%26.67M
Less:Non operating expense -59.20%6.52M-84.35%2.43M-52.19%508.1K-96.28%34.18M-97.37%15.99M161.22%15.56M65.97%1.06M-53.62%918.37M32,945.70%608.74M411.66%5.96M
Total profit 114.41%19.1M121.49%24.82M121.82%9.66M104.14%110.37M84.88%-132.55M40.16%-115.47M60.83%-44.3M-132.67%-2.66B12.19%-876.73M78.68%-192.96M
Less:Income tax cost -21.49%10.98M-30.20%6.7M-80.75%1.05M-77.14%6.8M68.18%13.99M275.97%9.59M451.13%5.46M-87.36%29.75M-70.88%8.32M-90.70%2.55M
Net profit FLtoP8.11MFLtoP18.12MFLtoP8.61MFLtoP103.57MFPtoL-146.54MFPtoL-125.06MFPtoL-49.77MSL-2.69BFPtoL-885.05MFPtoL-195.51M
Net profit from continuing operation 105.53%8.11M114.49%18.12M117.31%8.61M103.84%103.57M83.44%-146.54M36.03%-125.06M55.39%-49.77M-134.01%-2.69B13.83%-885.05M79.04%-195.51M
Less:Minority Profit 110.52%3.1M197.51%2.36M77.48%1.14M118.54%1.05M103.32%1.47M488.60%793.21K575.89%643.19K-381.56%-5.64M129.44%723.15K104.29%134.76K
Net profit of parent company owners 103.39%5.02M112.52%15.76M114.82%7.47M103.81%102.52M83.29%-148.01M35.67%-125.86M54.76%-50.41M-133.95%-2.69B13.55%-885.77M78.95%-195.65M
Earning per share
Basic earning per share --0111.11%0.001125.00%0.001105.26%0.0182.81%-0.01135.71%-0.00950.00%-0.004-133.33%-0.1913.51%-0.06479.10%-0.014
Diluted earning per share --0111.11%0.001125.00%0.001105.26%0.0182.81%-0.01135.71%-0.00950.00%-0.004-133.33%-0.1913.51%-0.06479.10%-0.014
Other composite income -781.50%-118.14K-1,878.74%-151.92K-3,977.41%-21.77K-158.78%-235.82K-556.27%-13.4K238.16%8.54K-533.98-88.44%401.22K-98.10%2.94K-98.41%2.53K
Other composite income of parent company owners -781.50%-118.14K-1,878.74%-151.92K-3,977.41%-21.77K-158.78%-235.82K-556.27%-13.4K238.16%8.54K---533.98-88.44%401.22K-98.10%2.94K-98.41%2.53K
Total composite income 105.45%7.99M114.37%17.97M117.26%8.59M103.84%103.33M83.44%-146.55M36.04%-125.06M55.39%-49.77M-133.99%-2.69B13.81%-885.04M79.03%-195.51M
Total composite income of parent company owners 103.31%4.9M112.40%15.61M114.78%7.45M103.81%102.29M83.29%-148.02M35.67%-125.85M54.76%-50.41M-133.93%-2.69B13.54%-885.77M78.95%-195.64M
Total composite income of minority owners 110.52%3.1M197.51%2.36M77.48%1.14M118.54%1.05M103.32%1.47M488.60%793.21K575.89%643.19K-381.56%-5.64M129.44%723.15K104.29%134.76K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianji International Accounting Firm (Special General Partnership)------Tianji International Accounting Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data